Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension

Circulation
B I Jugdutt

Abstract

We studied the effect of nitroglycerin-induced decreases in mean arterial pressure (MAP) on myocardial salvage. Two hours after occlusion of the left anterior descending coronary artery, 65 conscious dogs were randomly allocated to receive 4 hr intravenous infusions of saline (group 1, 19 dogs), or nitroglycerin in doses to decrease MAP by 10% (group 2, 18 dogs), 25% (group 3, 14 dogs), and 50% (group 4, 14 dogs), respectively. At 7 days, 41 dogs were killed for measurement of infarct size; 24 dogs, given 7 to 10 micron radioactive microspheres for flow calculations, were killed 6 hr after occlusion. Boundaries of the occluded bed were defined by postmortem coronary arteriography. Infarct and occluded bed masses were measured by planimetry of weighed transverse sections of the left ventricle. Compared with saline infusions in group 1, nitroglycerin infusions produced sustained reductions (p less than .001) in mean left atrial pressure and MAP in all dogs, but heart rate was unchanged. The decreases in MAP achieved in groups 2, 3, and 4 were 10% (range, 5% to 19%), 23%, and 39%, respectively, with average levels of 96 (range, 83 to 113), 83, and 64 mm Hg, respectively. Despite similar masses of the occluded bed and left ventricl...Continue Reading

References

Mar 1, 1979·Circulation·J Y Wei, P R Reid
Jan 2, 1975·The New England Journal of Medicine·S E EpsteinD R Redwood
Jan 1, 1975·Circulation·J T FlahertyB Pitt
Jun 1, 1975·The Journal of Clinical Investigation·R J BacheJ C Greenfield
Nov 1, 1973·The Journal of Clinical Investigation·M V CohenE S Kirk
Jan 1, 1983·American Heart Journal·F H SheehanS E Epstein
Jan 1, 1980·The American Journal of Cardiology·E MorcillioB Pitt
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman

❮ Previous
Next ❯

Citations

Aug 1, 1994·Cardiovascular Drugs and Therapy·B I Jugdutt
May 23, 1994·European Journal of Pharmacology·P A MartoranaR Henning
May 30, 1996·The American Journal of Cardiology·B I Jugdutt
Jan 1, 1986·Journal of the American College of Cardiology·B I Jugdutt, R W Amy
Dec 10, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M V MonzaniM Sardina
Feb 27, 2007·Vascular Health and Risk Management·Bodh I Jugdutt
Apr 1, 1990·The American Journal of the Medical Sciences·B G Firth, P M Dunnmon
Nov 24, 2011·Heart Failure Clinics·Bodh I Jugdutt
Jan 12, 2008·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Fuminobu IshikuraShintaro Beppu
Nov 18, 1991·The American Journal of Cardiology·B I Jugdutt
Sep 24, 1992·The American Journal of Cardiology·B I Jugdutt
Sep 1, 1989·Current Problems in Cardiology·R C Becker, J S Alpert
Dec 16, 1993·The American Journal of Cardiology·B I Jugdutt
Sep 15, 1989·The American Journal of Cardiology·B I Jugdutt, J W Warnica
Jul 1, 1989·DICP : the Annals of Pharmacotherapy·M F Babich, M L Kalin
Nov 23, 2020·Clinical Transplantation·Leonard NaymagonThomas Schiano
Jan 19, 1987·The Medical Journal of Australia·J D Horowitz, P J Henry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.